CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS — Stella

View on ClinicalTrials.gov

Recruiting

Back to HIV-1 trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(2 sites)

United States

City of Hope Medical Center, Duarte, California

UCSD, Division of Infectious Diseases and Global Public Health, San Diego, California

Key details

Phase

Very early testing

Sponsor

City of Hope Medical Center

Enrollment target

~15 participants

Started

December 2024

Primary completion

December 2026

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.